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Objective: All surgical methods published to date for the reduction of excessive high-flow in native elbow fistulas for
dialysis have limitations. We report a new surgical approach to flow reduction by transposition of the radial artery to the
elbow level.
Methods: From 1992 to 2008, 47 consecutive patients (22 women) with brachial artery to elbow vein autogenous fistula
underwent flow reduction via replacement of brachial artery by transposed distal radial artery inflow. Fistulas were
side-to-end either brachial-cephalic (19) or brachial-basilic (28). The indications were hand ischemia (4), cardiac failure
(13), concerns about future cardiac dysfunction (23), and chronic venous hypertension resulting in aneurysmal
degeneration of the vein (7). Mean patient age was 44 years, 11% were diabetic, 17% were smokers, and mean BMI was
22. Mean fistula age before flow reduction was 2.5 years.
Results:Technical success was 91% (43 of 47). Themean flow rate dropped by 66% 14%. Clinical success in symptomatic
patients was 75% (18 of 24). The fistula eventually had to be ligated in three cases of cardiac failure because of insufficient
clinical improvement. All four patients with hand ischemia were cured, with no recurrence during follow-up. Primary
patency rates at one and three years were 61%  7% and 40%  8%. Secondary patency rates at one and three years were
89%  5% and 70%  8%.
Conclusion: Transposition of the radial artery, a safe and effective technique, might now be considered in the surgical
armamentarium of flow reduction techniques. ( J Vasc Surg 2009;49:424-8.)Excessive high-flow is one of the many potential com-
plications of arteriovenous fistulas (AVF) for hemodialysis.
It may occur early after fistula construction, especially in
upper-arm autogenous fistulas fed by a large brachial artery.
Reduction of high-flow can be indicated to prevent or to
treat local or systemic complications such as hand ischemia
and cardiac insufficiency.1-5
The surgical techniques for flow reduction in elbow
fistulas reported to date include banding6,7 and distaliza-
tion of the anastomosis,8,9 also called revision using distal
inflow (RUDI).10 Both techniques have limitations and
complications. Banding can be too tight resulting in
thrombosis of the access, or too loose and therefore inef-
fective. The distalization technique described to date relies
on the interposition of a by-pass with a high risk of second-
ary stenosis at the venous anastomosis.
This is the reason why we use and now report a new
technique of flow reduction in proximal AVF involving
transposition of the radial artery from the forearm to the
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424elbow level in order to replace the brachial artery by the
distal radial artery inflow. This technique allows for signif-
icant flow reduction while preserving the functional and
previously matured upper arm vein for dialysis.
It is important to notice that the most popular DRIL
procedure11 and the proximalization of the arterial inflow
procedure (PAI)12 are two surgical techniques that have
been established as options only for the treatment of access
related ischemia by increasing pressure in the distal arteries
and not for the reduction of fistula flow. PAI is even
contraindicated when ischemia is associated with flow rates
above 800 mL/min.
PATIENTS AND METHODS
This single center retrospective study included 47 pa-
tients treated between April 1992 and January 2008. Pa-
tient characteristics are summarized in Table I.
Hand ischemia was the indication for fistula flow reduc-
tion in four patients and congestive heart failure in 13. In
23 patients, flow reduction was requested by nephrologists
in order to prevent potential long term detrimental cardiac
effects. A more recent indication (seven cases) was chronic
venous hypertension as a result of the combination of
brachial artery high-inflow and stenosis of venous outflow.
From a clinical point of view, such chronic venous hyper-
tension results in increased compression times after dialysis
and in aneurysmal degeneration of the vein. In these pa-
tients, surgical flow reduction by radial artery transposition
was associated with radiological percutaneous transluminal
angioplasty (PTA) of the outflow stenosis.
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Doppler ultrasonography (CDU), with manipulation and
image optimization operated by the same performer (GF)
with an ATLHDI 5000 scanner (Phillips Medical Systems,
Bothell, Wash). The SonoCT feature and harmonic imag-
ing was used in all cases. A linear probe 7-to-4 MHz was
used for deepest arterial segments and a 15-to-7 MHz for
more distal and superficial arteries. Flow measurement and
Doppler waveform analysis were performed on the brachial
artery13,14 or axillary artery in cases of high bifurcation of
the brachial artery. The diameter of the artery was deter-
mined by B-mode ultrasonography in a transverse plane
from inner edge to inner edge and the accuracy of the
measures was controlled by time/movement (TM) mode.
The cross-sectional area was automatically calculated.
Time averaged velocity (TAV) from Doppler spectra
were obtained with large sample volume size insonating
the entire luminal vessel in a longitudinal plane with an
insonating angle maintained below or equal to 60 de-
grees. Flow rates were calculated using the formula:
volume flow (ml/mm)  TAV (cm/s)  cross section
(cm2).
Flow rates were also calculated in relation to body
surface area (BSA) and expressed in mL/min per 1.73 m2
in order to normalize the volume flow estimates for all types
of patients (men, women, children, obese). BSA was calcu-
lated according to Mosteller’s formula: BSA (m2)  
[weight (kg)  height (cm)/3600].15 For example, the
lowest preoperative flow rate of operated patients was 800
mL/min in a three-year-old child of 10 kgs and corre-
sponded to 2993 mL/min per 1.73 m2. Pre- and postop-
erative flow rates are listed in Table II.
Surgical procedure. The absence of stenosis or occlu-
sion of the forearm arteries and palmar arches, a prerequi-
site for the intervention, was carefully assessed before inter-
vention by duplex ultrasound or angiography.
Surgery was performed under loco-regional anaesthesia
Table I. Patient characteristics
Characteristic Statistics
Patients 47
Age of patients (years) 44  21 (range, 3-82), (7  16 years)
Males/Females 25/22
AVF type Brachial-cephalic: 19Brachio-basilic: 28
Age of AVF (years) 2.5  2.1 (range, 8.9-0.1)
Diabetics 5
Smokers 8
Hypertension 24
BSA (m2) 1.54  0.41 (range, 0.46-2.10)
BMI 22  5 (range, 14-33)
Indications for flow
reduction
Ischemia: 4 (finger gangrene: 3, rest
pain: 1)
Cardiac failure: 13
Regarding cardiac outcome: 23
Venous hypertension: 7
AVF, Arteriovenous fistulas; BMI, body mass index; BSA, body surface area.and preventive hemostasis using an inflatable tourniquet,16without anticoagulation. The previous arteriovenous anas-
tomosis at the elbow was closed by division and suture of
the vein near the artery rather than ligation, which might
induce future aneurysmal degeneration of the juxta-arterial
segment of the vein. The radial artery was freed from the
forearm as a single block with its two concomitant veins, in
order to minimize arterial spasm, and then divided at the
wrist and turned upwards to reach the vein above the
elbow. A surgical microscope was used systematically for
creation of the new arteriovenous anastomosis which was
either end-to-end with arterial beveling, in order to adjust
the differences in diameter between the two vessels, or
preferably end-to-side from the artery to the vein. Patency
was checked intraoperatively using a sterile Doppler probe.
Figs 1 and 2 show a diagram and a postoperative view.
The intervention proved to be feasible even with calci-
fied arteries (n  6). There was no minimum radial artery
diameter required for the procedure, which was even per-
Table II. Pre- and postoperative mean flow rates
Flow
Preoperative Postoperative
mL/min
mL/min
per 1.73 m2 mL/min
mL/min
per 1.73 m2
Mean 1681 2012 577 678
SD 499 742 310 416
Max 3000 4554 1900 2569
Min 800* 919 170* 234
SD, Standard deviation.
*Child of 10 kg: preoperative flow  2993 mL/min per 1.73 m2.
Fig 1. Operating diagram. Number 1: brachial artery; 2: radial
artery after transposition; 3: ulnar artery; 4: cephalic or basilic vein;
5: previous arteriovenous anastomosis.
Fig 2. Postoperative view.formed in a 30-month child weighing 10 kgs.
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tive patency of the fistula checked by clinical and Doppler
examination and confirmed by immediate availability of the
fistula for the next dialysis session.
Technical efficacy was defined as a flow reduction of at
least 33% compared with preoperative figures. It was mea-
sured at one month follow-up by duplex ultrasound.
Clinical success was defined by regression of ischemia
and cardiac insufficiency (clinical and echocardiography
data), or normalization of bleeding times at the end of
dialysis treatments. Flow rates were then monitored by
duplex ultrasound on a yearly basis.
Patency rates after flow reduction by radial artery trans-
position were calculated according to the Life Table
method (Appendix, online only), in agreement with the
recommended reporting standards of the Society for Vas-
cular Surgery.17,18 Primary patency was defined as the
interval from the time of radial artery transposition until any
intervention designed to maintain or reestablish patency,
access thrombosis, or the time of measurement of patency.
Secondary patency was the time interval from radial artery
transposition until access abandonment, or the time of
patency measurement including surgical or endovascular
interventions designed to reestablish functionality in ste-
nosed or thrombosed access.
RESULTS
Both technical success (immediate post-operative pa-
tency) and efficacy rates (flow reduction  33%) were
91%  4% (same 43 of 47 patients). The mean postopera-
tive flow reduction rate was 66%  14% (range, 80% to
33%). The four immediate technical failures were due to
major technical difficulties in the creation of the new anas-
tomosis between the small caliber distal radial artery and
the large and thick-walled elbow vein. This resulted in
immediate acute thrombosis of the access. Thrombosis was
neglected in 2 cardiac patients, 2 patients were treated by
redo of the previous brachial artery anastomosis with no
subsequent ischemic complication despite the distal inter-
ruption of the radial artery. No other significant immedi-
ate postoperative complications occurred. The lowest
postoperative flow rates at 1 month after flow reduction
were 420 mL/min (400 mL/min per 1.73 m2) in adults
and 280 mL/min (586 mL/min per 1.73 m2) in chil-
dren. Median follow-up as of June 2008 was 20 months
(range, 0 to 189 months). No recurrence of high-flow was
observed at 48 months (Fig 3).
Clinical success in symptomatic patients was 75% (18 of
24). Three technical failures occurred in this subgroup (two
cardiac failure patients and one aneurysm patient). Three
patients with congestive heart failure were not sufficiently
improved and the fistula had to be ligated. The remaining
eight patients with cardiac insufficiency were clearly improved
according to clinical and cardiac echography findings. All 4
patients with hand ischemia (mean follow-up, 17 months)
were cured within 1 month, with no recurrence of symptoms
to date. Six patients with aneurysm met clinical success.During follow-up, 10 patients underwent renal trans-
plantation, 5 died (2 within 1 year). Nineteen patients with
insufficient flow or venous hypertension were treated by
PTA for stenoses at the arteriovenous anastomosis (nine) or
at the venous outflow (10). Seven of these patients had
already been treated by PTA for venous stenosis before flow
reduction. Two cases of acute thrombosis occurred and one
was successfully treated.
In terms of fistula patency (Fig 4), primary patency
rates (including initial failure cases) at 1, 2, and 3 years were
61%  7%, 50%  7%, and 40%  8%. Secondary patency
rates at 1, 2, and 3 years were 89%  5%, 82%  6%, and
70%  8%.
DISCUSSION
Banding was the first surgical technique described for
reducing excessive high-flow in dialysis fistulas. By contrast,
our experience with this technique was not positive, neither
in our hands, nor considering the numerous patients re-
ferred to us because of the failure of banding performed by
other surgeons. The banding proved to be either too tight,
Fig 3. Evolution of mean flow rates in operated patients.
Fig 4. Primary (solid line) and secondary (dashed line) patency
rates after radial artery transposition according to the Life Table
method and numbers for the patients at risk and standard errors
(between brackets) at the start of each interval.resulting in access thrombosis, or too loose and therefore
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with the publications of Odland2 and De Caprio,3 who
reported poor secondary patency rates of 38% and 9% at one
year. A more recent publication19 has reported more favor-
able short or mid-term results using access flow rate mon-
itoring during banding procedures. However, this single
report of better outcomes needs to be confirmed. In our
experience, intraoperative flow measurement might not be
reliable possibly because of vascular flow modifications
related to regional or general anesthesia and to spasm
caused by surgical dissection.
Flow rates in our study were calculated using CDU, a
reliable method in experienced hands. Although CDU
assessment of access flow is performed in the dialysis-free
period whereas the ultrasound dilution technique20 must
be performed during hemodialysis sessions, comparative
studies21,22 showed that the results of the two techniques
were in agreement (correlation coefficients of 0.83 and
0.79). On the other hand, measurements performed with
the ultrasound dilution technique were nevertheless re-
ported to be often lower than those calculated by magnetic
resonance.23 The slight discrepancy might be explained by
the temporary reduction of access flow due to an increased
dissipation of energy caused by the reversal of needles
associated with the ultrasound dilution technique.
The other ways of reducing flow are distalization of the
anastomosis - RUDI techniques,8-10 involving the interpo-
sition of a bypass between the radial artery and the elbow
vein in order to replace the large brachial artery inflow by
the smaller distal radial artery inflow. In addition, this long
segment of conduit creates resistance to arterial flow as
predicted by Poiseuille’s law. In the largest published series
of 35 patients,8 the mean flow reduction rate was 60% 
18%. Unfortunately, this series also reported that the devel-
opment of stenoses at the venous anastomosis of the grafts
occurred rapidly, especially in children,24 jeopardizing ac-
cess patency. The drawbacks of the above-mentioned tech-
niques are the reasons why we have tried to develop this
new technique using only native vessels.
Radial artery transposition was done using preventive
hemostasis with a tourniquet16 making extensive exposi-
tion and control of the brachial artery unnecessary before
section of the vein adjacent to the original arteriovenous
anastomosis. Patch-like suture of the vein prevents imme-
diate narowing of the brachial artery and future aneurysmal
degeneration of the juxta-artery venous segment that
might occur after ligation.
The two major technical difficulties in this surgery of
radial artery transposition are spasm and construction of the
new anastomosis. Prevention of arterial spasm involved the
use of regional anesthesia and a technique of dissection
of the radial artery including its satellite veins. With regard
to the creation of the new anastomosis, the key problem
was the major difference in diameter and wall thickness
between the small radial artery and the larger previously
arterialized vein. We initially performed end-to-end anas-
tomoses with arterial beveling using non-interrupted su-
tures but we finally moved to an end-to-side technique withinterrupted sutures. Our opinion is that the anastomosis is
better performed using a microscope. However, there is a
learning curve, as for any surgical technique.
It can be seen from our follow-up data that further
stenoses can develop or progress in the vein itself (n  10)
and in the anastomotic area (n  9). Close monitoring of
these fistulas after intervention is therefore mandatory,
since acute thrombosis might not be easy to recover.
It is understandable that colleagues might be reluctant
to suppress the radial artery inflow to the hand, especially in
the sub-group of patients with hand ischemia.However, we
emphasize that this technique of radial artery transposition
was performed only in cases of excessive high-flow originat-
ing from the brachial artery, and only when the ulnar artery
and palmar arches were clearly patent. In contrast to the
DRIL procedure which includes the ligation of the brachial
artery, it is the radial artery and not the brachial artery that
is ligated.
As preoperative AVF flow rates before DRIL are usually
not mentioned in the literature, the real incidence of high-
flow fistula and therefore the indications for flow reduction
in the treatment of ischemia might have been underesti-
mated up today.
The detrimental effects of arteriovenous fistulas on the
heart are extremely difficult to assess and this is a subject of
controversy. Our experience shows that eight out of 13
patients with cardiac insufficiency were clearly improved
after fistula flow reduction. However, it is at present impos-
sible to draw straightforward conclusions for the 23 asymp-
tomatic patients referred by nephrologists for prevention of
potential long-term deleterious effects of high-flow on
cardiac function. Some publications25 have reported a re-
duction of the left ventricular mass (LVM) after fistula
ligation in transplanted patients, and such LVM reduction
is correlated with decreased cardiovascular risk. A similar
benefit might be expected from fistula flow reduction but
nothing has been proven to date for asymptomatic patients.
Two recent publications have conflicting results. The find-
ings of the North American series26 do not suggest an
increased risk of death at higher levels of access blood flow
whereas the European study27 might be the first to have
shown a high predictive value for high-output cardiac fail-
ure occurrence of flow values above two L/minute. Any-
way, the current debate will not be solved by surgeons. The
goal of this article is to report a new technique of fistula flow
reduction that might help surgeons to face a potential
increasing request from nephrologists. In our experience, it
was difficult not to favorably answer to the clinical require-
ment of nephrologists that had in mind several cases of
acute pulmonary edema inaugurating cardiac failure in
patients with a delayed diagnosis of high-flow fistulas.
Chronic venous hypertension is an emerging new indi-
cation (n  7). It is well known that brachial-cephalic
fistulas frequently develop stenosis in the final arch of the
cephalic vein or in the upper part of the transposition of the
basilic vein. Fistula high-flow chronically collides with these
venous outflow obstructions, which causes permanent ve-
nous hypertension resulting in aneurysmal degeneration of
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prolonged bleeding times at needle removal and skin vul-
nerability with risk of focal necrosis. Most surgeons or
interventionists are reluctant to reopen fully (by dilatation)
these outflow vein stenoses in view of the risks of subse-
quent excessive high flow which might increase consider-
ably, for example to above three L/minute, or cause hand
ischemia. We experienced such complications in the past.
The best treatment might be concomitant stenosis treat-
ment and flow reduction surgery, using our method of
radial artery transposition whenever technically feasible.
CONCLUSION
Whatever the indication (hand ischemia, cardiac failure,
aneurysmal degeneration of the vein, concerns regarding
cardiac outcome), transposition of the radial artery to re-
duce the flow of an elbow fistula is a safe and effective
technique which might be now considered in the surgical
armamentarium.
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Interval (mo)
N° at risk at
beginning of interval
N° fai
during in
Primary patency life table
0 47 4
3 43 7
6 33 3
12 27 3
24 23 4
36 17 3
48 10 1
Secondary patency life table
0 47 4
3 43 0
6 36 1
12 32 0
24 29 2
36 23 3
48 15 4led
terval
Withdrawn
during interval
Interval
failure rate
Cumulative
patency rate
Standard
error
0 0.085 91% 4%
3 0.169 76% 6%
3 0.095 69% 7%
1 0.113 61% 7%
2 0.182 50% 7%
4 0.200 40% 8%
3 0.118 35% 9%
0 0.085 91% 4%
7 0.000 91% 4%
3 0.029 89% 5%
3 0.000 89% 5%
4 0.074 82% 6%
5 0.146 70% 8%
